News & Updates

Anaphylactic reactions warranting treatment after receipt of COVID-19 mRNA vaccinations appear to be relatively rare, according to a US study presented at AAAAI 2022.

Olfactory and gustatory dysfunctions, even when assessed through validated psychophysical tests, are common chronic symptoms after the coronavirus disease 2019 (COVID-19), a recent study has found.

Community-acquired severe pneumonia is more likely to develop in young boys and children with severe stunting, reports a recent study. Fever, illness duration, and a history of prior medical care are also important predictive factors for severe pneumonia.

Patients successfully treated with direct-acting antivirals (DAAs) show high knowledge about hepatitis C virus (HCV) infection, a recent study has shown.

Nonantibiotic treatment with methenamine hippurate shows high levels of efficacy in women with a history of recurrent episodes of urinary tract infection (UTI), which is comparable to the current guideline-recommended prophylaxes (ie, long-course, low-dose antibiotics), according to a study.

Antecedent use of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) among older COVID-19 patients with hypertension results in fewer all-cause deaths, whether in-hospital or shortly after discharge, compared with no antecedent use of renin-angiotensin system inhibitors (RASIs), a study has shown.

Prior to the COVID-19 pandemic, life expectancy at age 70 years has continued to rise across the globe due to reductions in chronic diseases, according to a recent study. However, disability burden persists and indicates the need to improve public health and intervention initiatives to enhance well-being among older adults.